ZOTA (ZOTA): Acquisition / M&A

Strota Newsroom · session of 2026-07-17 · 17 Jul 16:39 · ZOTA stock page →

ZOTA: Zota Health Care Limited has informed the Exchange about Intimation of Acquisition of 2,35,512 equity shares of M/… Historically, acquisition / m&a events have moved ZOTA-type stocks in the bullish direction 48.9% of the next sessions (n=141).

Zota Health Care Limited has informed the Exchange about the acquisition of 2,35,512 equity shares of M/s Davaindia Health Mart Limited, its wholly owned subsidiary, on a preferential basis for consideration other than cash, according to an NSE filing dated 17 July 2026. The company has announced multiple acquisition events in recent weeks, including the purchase of an 80% stake in M/s Globotask IT Consultancy Services Private Limited and subscriptions to rights issues of two other wholly owned subsidiaries, Curexis Ventures Private Limited and KMHP Ventures Limited.

Events like this have historically shown a 48.9% win rate with a net edge of 0.213% across 141 comparable acquisition announcements, Strota data shows. This base rate reflects how similar M&A events have performed on average across many past stocks, not a forecast for Zota specifically.

The stock currently trades at a price-to-book ratio of 13.1 with a market capitalisation of ₹4,094 crore. The company reported negative earnings per share of ₹-22.52 and a return on equity of -16.0%. The dividend yield stands at 0.07%. The Nifty rose 1.09% on the session.

The filing confirms the share acquisition and its non-cash consideration structure. It does not establish the strategic rationale, future earnings impact, or whether the transaction alters consolidated financials. The historical base rate offers context on how markets have processed similar announcements, not predictive guidance for this position.

The catalyst

ZOTA: Zota Health Care Limited has informed the Exchange about Intimation of Acquisition of 2,35,512 equity shares of M/s Davaindia Health Mart Limited, Wholly Owned Subsidiary of the Company, on a preferential basis for consideration other than cash. (filing · NSE)

What the data shows after this event

Across Strota's backtest of past filings, Acquisition / M&A shows no reliable next-session edge — the move went bullish in about 48.9% of next sessions (net 0.213% after drift and cost, n=141). A base rate, not a forecast for this stock.

ZOTA right now

Live price and flow context is on the stock's analysis page.. Full ZOTA analysis →

Sources

Keep digging

How this article was made: Strota assembled the exchange data above (prices, F&O open interest, bulk/block deals, SEBI PIT filings, indicator readings and public headlines) and an AI model wrote the narrative strictly from that evidence — it is not permitted to add outside facts or numbers. Every figure comes from the underlying exchange/public data.